Market Insider

Rivian electric pickup trucks sit in a parking lot at a Rivian service center on May 09, 2022 in South San Francisco, California. 
Justin Sullivan | Getty Images

Check out the companies making headlines after hours.

Rivian — Shares of the electric vehicle maker increased 2.7% after announcing after the bell that production met expectations in its quarter ending Sept. 30.

Dynatrace — The software intelligence company jumped 4.6% after being upgraded to a buy from JPMorgan. Earlier, the stock rose 3% during regular trading.

Kezar Life Sciences — Shares of the biotechnology company were up 2.3% after it announced FDA clearance of its investigational new drug application for an autoimmune hepatitis treatment.

Rocket Pharmaceuticals — The stock dropped 4.6% after the company started a $100 million secondary. Underwriters have a 30-day option to purchase up to $15 million in additional shares.

Articles You May Like

Market Watch: How Trump’s Tariff Strategy Could Reshape This Rally
Caligan picks up a stake in Verona Pharma, seeing an opportunity to generate more value
David Einhorn to speak as the priciest market in decades gets even pricier postelection
BlackRock expands its tokenized money market fund to Polygon and other blockchains
Trump is the most pro-stock market president in history, Wharton’s Jeremy Siegel says